Designed for M5Stack Atom, AtomS3, and AtomS3R series IoT controllers based on ESP32 or ESP32-S3 wireless SoC, the Echo Pyramid base enables smart voice ...

Scientists have taken a major step toward mimicking nature’s tiniest gateways by creating ultra-small pores that rival the dimensions of biological ion channels—just a few atoms wide. The breakthrough ...

All the Latest Game Footage and Images from Rise of Atom A retro-futuristic, sci-fi, turn-based management RPG. Become the CEO of an R&D behemoth: hire scientists, woo investors, dabble in corporate ...

Atom Willard has left Alkaline Trio. He stated: "With everything going on, going wrong, in the world right now this may seem insignificant, but it’s not for me. I have parted ways with Alkaline Trio.

While Bethesda has made its position very clear on Fallout game locations (it'll never stray outside of the United States) that doesn't stop people dreaming about exploring irradiated wastelands in ...

Willard announced his departure from Alkaline Trio in an Instagram post on Monday (Feb. 2). "With everything going on, going wrong in the world right now, this may seem insignificant but it's not for ...

Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...

In order to scale quantum computers, more qubits must be added and interconnected. However, prior attempts to do this have resulted in a loss of connection quality, or fidelity. But, a new study ...

DC Comics‘ latest major storyline, DC K.O., pits many of the universe’s strongest heroes and villains against each other in vicious battles. With the second round underway, the remaining characters ...

An advanced nuclear startup just achieved a milestone as it races to meet an ambitious Department of Energy goal. Founded just over two years ago in July 2023, El Segundo-based Valar Atomics announced ...

Atom’s lingdolinurad (ABP-671), a URAT1 inhibitor, is in late stage global clinical trials for chronic gout and ABP-745, an anti-inflammatory drug, is in multi-country Phase 2 trials for acute gout ...